Fetal phthalates and bisphenols and childhood lipid and glucose metabolism. A population-based prospective cohort

Chalana M Sol1, Susana Santos1, Liesbeth Duijts1

  • 1The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands; Department of Paediatrics, Erasmus MC - Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Environment International
|September 5, 2020
PubMed

Insights

Fetal exposure to phthalates and bisphenols may affect children's metabolism. Maternal phthalate and bisphenol levels during pregnancy were linked to altered lipid, glucose, and insulin levels in boys at school age.

Area of Science:

  • Environmental Health
  • Pediatric Endocrinology
  • Metabolic Health

Background:

  • Endocrine-disrupting chemicals (EDCs) like phthalates and bisphenols are environmental contaminants.
  • Fetal exposure to EDCs may induce metabolic adaptations with long-term consequences.
  • Understanding the impact of prenatal EDC exposure on child metabolic health is crucial.

Purpose of the Study:

  • To investigate the association between maternal urinary concentrations of phthalates and bisphenols during pregnancy and offspring's lipid, glucose, and insulin levels at school age.
  • To explore potential sex-specific effects of prenatal EDC exposure on metabolic parameters.

Main Methods:

  • Population-based prospective cohort study of 757 mother-child pairs.
  • Maternal urine samples collected during first, second, and third trimesters of pregnancy.
  • Child blood samples analyzed for non-fasting lipids, glucose, and insulin at mean age 9.7 years.

Main Results:

  • Higher third-trimester maternal phthalic acid concentration associated with increased triglycerides in boys.
  • Higher second-trimester maternal high molecular weight phthalates (HMWP) and di-2-ethylhexylphthalate (DEHP) associated with lower glucose in boys.
  • Higher third-trimester maternal bisphenol F concentration associated with lower insulin in boys.

Conclusions:

  • Prenatal exposure to certain phthalates and bisphenols may have persistent, sex-specific effects on childhood lipid and glucose metabolism.
  • Findings highlight the potential for EDCs to disrupt normal metabolic development.
  • Further research is warranted to confirm these findings and elucidate underlying mechanisms.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
108
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.8K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
168
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
145
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
35.4K